Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Diazepam Buccal Film in Epilepsy
NCT03428360Phase 3Completed
- Sponsor
- Aquestive Therapeutics
- Start
- Jan 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diazepam nasal spray in epilepsy, sponsored by Aquestive Therapeutics. Started Jan 2018; status: completed.
02
Drugs
diazepam nasal spray
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03428360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03428360.